DuPont CEO gives investors confidence Dow deal is on track
Company says Q1 income will decline about 18% from a year earlier, partly because of a merger-related expense
Houston
DUPONT Co said it can address antitrust regulators' concerns that its merger with Dow Chemical Co could limit discovery of new agricultural pesticides, boosting investor confidence that the US$72 billion deal will be approved.
Regulators are mostly concerned that the combination could hurt innovation in crop-protection chemicals, chief executive officer Ed Breen said on Tuesday on a conference call to discuss fourth-quarter results.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife customers push for legal action